Singapore-based healthcare-focused investment firm NSQ Capital has completed an investment in Anh Sang International Eye Group. The strategic transaction adds momentum to the growing wave of private equity investment in Vietnam’s specialized healthcare sector.
Transaction Details and Investment Platform
Although the transaction’s valuation and financial terms were not disclosed, available information indicates that the deal was structured as a strategic partnership. The founding shareholder group, led by Prof. Dr. Ton Thi Kim Thanh, MD—President of the Vietnam Ophthalmological Society and founder of the Anh Sang brand in 2009—will retain a controlling stake and continue to oversee the Group’s core clinical operations.
The investment from NSQ Capital, founded by Dr. Shawn Ng, extends beyond the provision of growth capital and focuses on four strategic pillars:
Network expansion: Expanding the Group’s footprint through both new facility development (greenfield) and acquisitions of existing operators (brownfield M&A), with the ambition of growing beyond its current network of four hospitals in northern Vietnam to establish a nationwide presence.
Technology upgrades and digital transformation: Investing in advanced diagnostic systems and digital infrastructure to improve operational efficiency.
Standardized clinical governance: Introducing healthcare governance practices aligned with international standards, drawing on Singapore’s experience and expertise.
Workforce development: Establishing clinical fellowship and training programs to develop the next generation of ophthalmologists.
M&A Perspective: Why Ophthalmology Is Attracting Investment
From a healthcare M&A perspective, the NSQ Capital–Anh Sang transaction reflects three key growth drivers shaping Vietnam’s private healthcare market.
A Fragmented Market Poised for Consolidation
Vietnam’s private healthcare sector remains fragmented across small and mid-sized clinics and hospitals. Private equity firms are increasingly entering the market as platform investors, consolidating smaller operators into scaled healthcare networks—a strategy widely used across Southeast Asia to enhance operational efficiency and optimize valuations.
Disease Trends and an Ageing Population
School-age myopia has reached concerning levels, reportedly affecting up to 80% of students in some areas. Combined with Vietnam’s rapidly ageing population, this is driving strong demand for cataract, retinal and glaucoma treatment, as well as other advanced ophthalmology services.
Attractive Margins from Elective Procedures
Unlike many general medical specialties, ophthalmology derives a significant share of revenue from refractive surgery, aesthetic eye procedures and other elective treatments. These services typically generate faster cash flows and offer attractive margins for investors.
Long-Term Strategic Direction
Dr. Vu Thi Thanh, CEO of Anh Sang International Eye Group, said the partnership would provide a strategic platform for the brand to evolve from a regional healthcare network into a national healthcare institution.
The combination of the local medical team’s extensive clinical expertise and NSQ Capital’s financial and management capabilities is expected to establish a new benchmark for private healthcare M&A transactions in Vietnam in the years ahead.
Compiled and analyzed by MAVIET.VN. Transaction information is based on the companies’ partnership announcement and reporting by DealStreetAsia
——————————–
Vietnam M&A Solutions Co., Ltd
Address: No. 47 Nguyen Tuan, Thanh Xuan Ward, Hanoi, Vietnam
Tel: +84 559 322 322
Email: info@maviet.vn
Website: maviet.vn
